Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
42.46
+1.96 (4.84%)
At close: Jun 26, 2026, 4:00 PM EDT
43.09
+0.63 (1.49%)
After-hours: Jun 26, 2026, 7:53 PM EDT
Vera Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Vera Therapeutics stock have an average target of 84.6, with a low estimate of 56 and a high estimate of 110. The average target predicts an increase of 99.25% from the current stock price of 42.46.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vera Therapeutics stock from 14 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 12 | 12 | 12 | 12 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 25, 2026 |
Unknown Analyst Wells Fargo No rating | Wells Fargo | Buy Maintains $70 | Buy | Maintains | $70 | +64.86% | Jun 12, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $100 | Buy | Maintains | $100 | +135.52% | Jun 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $110 | Buy | Maintains | $110 | +159.07% | Jun 5, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $90 | Buy | Maintains | $90 | +111.96% | Jun 3, 2026 |
Financial Forecast
Revenue This Year
38.02M
Revenue Next Year
253.52M
from 38.02M
Increased by 566.77%
EPS This Year
-6.29
from -4.66
EPS Next Year
-3.80
from -6.29
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 73.6M | 509.3M | |
| Avg | 38.0M | 253.5M | |
| Low | 12.1M | 130.2M |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 1,239.5% | 333.9% |
| Avg | 566.8% | 158.8% |
| Low | 242.5% | 50.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -5.56 | -2.08 | |
| Avg | -6.29 | -3.80 | |
| Low | -7.39 | -5.40 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.